Transcorneal Permeation of Ciprofloxacin and Diclofenac from Marketed Eye Drops
2008

Transcorneal Permeation of Ciprofloxacin and Diclofenac from Marketed Eye Drops

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): Patidar N. Rathore, M. S. Sharma, D. K. Middha, A. Gupta

Primary Institution: B.R. Nahata College of Pharmacy

Hypothesis

This study was designed to evaluate in vitro permeation characteristics of marketed eye drops of ciprofloxacin and diclofenac through isolated goat cornea.

Conclusion

The study found that all tested eye drops of ciprofloxacin and diclofenac did not harm goat eye lenses and may even provide protective effects.

Supporting Evidence

  • Joxin showed maximum in vitro transcorneal permeation of ciprofloxacin at 0.558%.
  • I-Gesic showed maximum % permeation of diclofenac at 5.73%.
  • All formulations showed more soluble protein content compared to control, indicating protective effects on eye lenses.

Takeaway

The eye drops tested are safe for goat eyes and can help protect them from damage.

Methodology

In vitro permeation studies were conducted using isolated goat cornea and eye lenses, with drug concentrations measured spectrophotometrically.

Limitations

The study was conducted in vitro, and further in vivo studies are needed to confirm the findings.

Participant Demographics

Isolated goat corneas and lenses were used for the experiments.

Digital Object Identifier (DOI)

10.4103/0250-474X.45409

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication